Literature DB >> 25620630

Neuroprotective mechanisms of the ACE2-angiotensin-(1-7)-Mas axis in stroke.

Douglas M Bennion1, Emily Haltigan, Robert W Regenhardt, U Muscha Steckelings, Colin Sumners.   

Abstract

The discovery of beneficial neuroprotective effects of the angiotensin converting enzyme 2-angiotensin-(1-7)-Mas axis [ACE2-Ang-(1-7)-Mas] in ischemic and hemorrhagic stroke has spurred interest in a more complete characterization of its mechanisms of action. Here, we summarize findings that describe the protective role of the ACE2-Ang-(1-7)-Mas axis in stroke, along with a focused discussion on the potential mechanisms of neuroprotective effects of Ang-(1-7) in stroke. The latter incorporates evidence describing the actions of Ang-(1-7) to counter the deleterious effects of angiotensin II (AngII) via its type 1 receptor, including anti-inflammatory, anti-oxidant, vasodilatory, and angiogenic effects, and the role of altered kinase-phosphatase signaling. Interactions of Mas with other receptors, including bradykinin receptors and AngII type 2 receptors are also considered. A more complete understanding of the mechanisms of action of Ang-(1-7) to elicit neuroprotection will serve as an essential step toward research into potential targeted therapeutics in the clinical setting.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25620630      PMCID: PMC4378688          DOI: 10.1007/s11906-014-0512-2

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  108 in total

1.  The angiotensin II AT2 receptor is an AT1 receptor antagonist.

Authors:  S AbdAlla; H Lother; A M Abdel-tawab; U Quitterer
Journal:  J Biol Chem       Date:  2001-08-15       Impact factor: 5.157

2.  A heterodimer-selective agonist shows in vivo relevance of G protein-coupled receptor dimers.

Authors:  Maria Waldhoer; Jamie Fong; Robert M Jones; Mary M Lunzer; Shiv K Sharma; Evi Kostenis; Philip S Portoghese; Jennifer L Whistler
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-02       Impact factor: 11.205

3.  Stimulation of AT2 receptor exerts beneficial effects in stroke-prone rats: focus on renal damage.

Authors:  Paolo Gelosa; Alice Pignieri; Lars Fändriks; Marc de Gasparo; Anders Hallberg; Cristina Banfi; Laura Castiglioni; Lucia Turolo; Uliano Guerrini; Elena Tremoli; Luigi Sironi
Journal:  J Hypertens       Date:  2009-12       Impact factor: 4.844

4.  Angiotensin-(1-7) upregulates cardiac nitric oxide synthase in spontaneously hypertensive rats.

Authors:  María A Costa; María A Lopez Verrilli; Karina A Gomez; Pablo Nakagawa; Clara Peña; Cristina Arranz; Mariela M Gironacci
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-07-30       Impact factor: 4.733

5.  Suppressing inflammation by inhibiting the NF-κB pathway contributes to the neuroprotective effect of angiotensin-(1-7) in rats with permanent cerebral ischaemia.

Authors:  Teng Jiang; Li Gao; Jun Guo; Jie Lu; Yao Wang; Yingdong Zhang
Journal:  Br J Pharmacol       Date:  2012-12       Impact factor: 8.739

6.  Protection from angiotensin II-induced cardiac hypertrophy and fibrosis by systemic lentiviral delivery of ACE2 in rats.

Authors:  Matthew J Huentelman; Justin L Grobe; Jorge Vazquez; Jillian M Stewart; Adam P Mecca; Michael J Katovich; Carlos M Ferrario; Mohan K Raizada
Journal:  Exp Physiol       Date:  2005-07-27       Impact factor: 2.969

7.  G-protein-coupled receptor Mas is a physiological antagonist of the angiotensin II type 1 receptor.

Authors:  Evi Kostenis; Graeme Milligan; Arthur Christopoulos; Carlos F Sanchez-Ferrer; Silvia Heringer-Walther; Patrick M Sexton; Florian Gembardt; Elaine Kellett; Lene Martini; Patrick Vanderheyden; Heinz-Peter Schultheiss; Thomas Walther
Journal:  Circulation       Date:  2005-04-04       Impact factor: 29.690

8.  Anti-inflammatory effects of the activation of the angiotensin-(1-7) receptor, MAS, in experimental models of arthritis.

Authors:  Kátia Daniela da Silveira; Fernanda Matos Coelho; Angélica Thomáz Vieira; Daniela Sachs; Lívia Corrêa Barroso; Vivian Vasconcelos Costa; Thales Lages Bicalho Bretas; Michael Bader; Lirlândia Pires de Sousa; Tarcília Aparecida da Silva; Robson Augusto Souza dos Santos; Ana Cristina Simões e Silva; Mauro Martins Teixeira
Journal:  J Immunol       Date:  2010-10-08       Impact factor: 5.422

9.  Candesartan pretreatment is cerebroprotective in a rat model of endothelin-1-induced middle cerebral artery occlusion.

Authors:  Adam P Mecca; Timothy E O'Connor; Michael J Katovich; Colin Sumners
Journal:  Exp Physiol       Date:  2009-05-08       Impact factor: 2.969

Review 10.  Angiotensin converting enzyme 2 and atherosclerosis.

Authors:  Yutang Wang; Chris Tikellis; Merlin C Thomas; Jonathan Golledge
Journal:  Atherosclerosis       Date:  2012-08-20       Impact factor: 5.162

View more
  30 in total

Review 1.  Significance of angiotensin 1-7 coupling with MAS1 receptor and other GPCRs to the renin-angiotensin system: IUPHAR Review 22.

Authors:  Sadashiva S Karnik; Khuraijam Dhanachandra Singh; Kalyan Tirupula; Hamiyet Unal
Journal:  Br J Pharmacol       Date:  2017-03-09       Impact factor: 8.739

Review 2.  Macrophages in neuroinflammation: role of the renin-angiotensin-system.

Authors:  Anna Hammer; Johannes Stegbauer; Ralf A Linker
Journal:  Pflugers Arch       Date:  2017-02-11       Impact factor: 3.657

3.  125I-Angiotensin 1-7 binds to a different site than angiotensin 1-7 in tissue membrane preparations.

Authors:  Filipe F Stoyell-Conti; Sarin Itty; Christy Abraham; Katya Rigatto; Crystal A West; Robert C Speth
Journal:  Endocrine       Date:  2021-01-07       Impact factor: 3.633

4.  Stimulation of ACE2/ANG(1-7)/Mas Axis by Diminazene Ameliorates Alzheimer's Disease in the D-Galactose-Ovariectomized Rat Model: Role of PI3K/Akt Pathway.

Authors:  Ahmed S Kamel; Noha F Abdelkader; Sahar S Abd El-Rahman; Marwan Emara; Hala F Zaki; Mahmoud M Khattab
Journal:  Mol Neurobiol       Date:  2018-03-07       Impact factor: 5.590

5.  MAS1 Receptor Trafficking Involves ERK1/2 Activation Through a β-Arrestin2-Dependent Pathway.

Authors:  Flavia M Cerniello; Oscar A Carretero; Nadia A Longo Carbajosa; Bruno D Cerrato; Robson A Santos; Hernán E Grecco; Mariela M Gironacci
Journal:  Hypertension       Date:  2017-09-05       Impact factor: 10.190

Review 6.  Angiotensin II Signal Transduction: An Update on Mechanisms of Physiology and Pathophysiology.

Authors:  Steven J Forrester; George W Booz; Curt D Sigmund; Thomas M Coffman; Tatsuo Kawai; Victor Rizzo; Rosario Scalia; Satoru Eguchi
Journal:  Physiol Rev       Date:  2018-07-01       Impact factor: 37.312

Review 7.  Role of neurons and glia in the CNS actions of the renin-angiotensin system in cardiovascular control.

Authors:  Annette D de Kloet; Meng Liu; Vermalí Rodríguez; Eric G Krause; Colin Sumners
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2015-06-17       Impact factor: 3.619

Review 8.  Angiotensin-(1-7) and Alamandine on Experimental Models of Hypertension and Atherosclerosis.

Authors:  Fernando Pedro de Souza-Neto; Melissa Carvalho Santuchi; Mario de Morais E Silva; Maria José Campagnole-Santos; Rafaela Fernandes da Silva
Journal:  Curr Hypertens Rep       Date:  2018-03-14       Impact factor: 5.369

9.  Modulation of brain ACE and ACE2 may be a promising protective strategy against cerebral ischemia/reperfusion injury: an experimental trial in rats.

Authors:  Maha Mohammed Abdel-Fattah; Basim Anwar Shehata Messiha; Ahmed Mohamed Mansour
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-06-17       Impact factor: 3.000

Review 10.  Functional ACE2 deficiency leading to angiotensin imbalance in the pathophysiology of COVID-19.

Authors:  Joshua R Cook; John Ausiello
Journal:  Rev Endocr Metab Disord       Date:  2021-07-01       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.